The present study examines the molecular mechanism underlying in vitro-induced resistance to FLC (fluconazole), KTC (ketaonazole), MCZ (miconazole) and CHX (cycloheximide) in AS (azole-susceptible) strains of Candida albicans when exposed to CaCDR1/CaCDR2 inducers like FPZ (fluphenazine) and steroids [PRG (progesterone) and β-EST (β-oestradiol)]. By employing spot and checkerboard titre assays, we provide evidence of an in vitro-induced antagonism between tested drugs and inducers, which was accompanied with a concomitant increase in CaCDR1 and CaCDR2 transcript levels. Notably, unlike AS isolates, parental WT (wild-type) and cdr2 null strains, cdr1 as well as cdr1/ cdr2 nulls, when challenged with the inducers could not display antagonism. Our results validated by Northern blotting, reporter gene transcription and TRO (transcription run on) assays show that in vitro-induced antagonism between tested drugs and inducer in AS isolates was mainly due to a transient and reversible transcriptional activation of CaCDR1. Notwithstanding our earlier observation that consistent high transcript levels of CaCDR1 in clinical AR (azole-resistant) isolates were maintained due to the combination of its transcriptional activation and enhanced mRNA stability via elongated poly(A) tails, this study shows that transient and reversible transcriptional activation of CaCDR1 was the major determinant of induced antagonism in AS isolates. The distinct strategies between sustained (in AR isolates) and transiently induced resistance mechanisms (in AS isolates) adopted by Candida should become useful in improving therapeutic approaches.
INTRODUCTION
Azoles, which target the ergosterol biosynthesis pathway by inhibiting the P450 cytochrome 14α-lanosterol demethylase (CaERG11), are frontline antifungals most commonly used to treat Candida albicans infections [1] . However, repeated and prolong usage of azoles leads to the development of AR (azoleresistant) strains. Biochemical and molecular analyses of AR strains have shown that factors contributing to the development of clinical resistance are numerous and include the extent of immuno-suppression of host, level of exposure to azoles and intrinsic resistance of the fungus to antifungal drugs [2] 
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Regulation at transcription level is generally accepted to be the principal mechanism for controlling the MDR gene expression and so is the case with CaCDR1 for its transient and consistent up-regulation in clinical AS (azole-susceptible) and AR isolates respectively [7] [8] [9] [10] . The identification of various consensus and specific cis-regulatory elements as well as trans-acting factors matches well with the transcriptional regulation of CaCDR1 [9] [10] [11] [12] [13] [14] [15] [16] [17] . It has been shown earlier that CaCDR1 in its 5 flanking region harbours various consensus [Sp1 (specificity protein 1), AP-1 (activator protein 1) and Y-box] sequences as well as specific BRE (basal response element), NRE (negative response element) and DRE (drug response element)/SRE (steroid response element) [9] [10] [11] [12] . Various trans-acting factors regulating CaCDR1 expression have also been identified. For example, Non DiTyrosine 80 [CaNDT80, a homologue of a meiosis-specific TF (transcription factor)] in Saccharomyces cerevisiae has been identified as a potential activator of CaCDR1 [13] . Coste et al. [14] identified a TF TAC1 (Transcriptional Activator of CDR genes 1) that binds to the DRE in CaCDR1/CaCDR2 promoters. In contrast, TF belonging to the zinc cluster family, FCR1 (Fluconazole Resistance 1) [15] , as well as the global repressor, Tup1 (Thymidine uptake 1), acts as a negative regulator of CaCDR1 expression [16] . Recent genome-wide location profiling [ChIP (chromatin immunoprecipitation)-chip] shows that another TF of the zinc cluster family, Upc2 (Uptake control 2), regulating ERG genes, also targets CaCDR1 [17] . However, our recent studies have shown that along with the transcriptional control, post-transcriptional event involving mRNA stability governed by hyperadenylation of its 3 -UTR (3 -untranslated region) also regulates CaCDR1 levels in clinical AR isolates [8, 18] . A number of studies indicate that hMDR1 (human CaCDR1 homologue) encoding P-gp (P-glycoprotein) can be rapidly and transiently induced in vitro in cultured cell lines on exposure to a variety of chemotherapeutic agents by either its transcriptional activation or by enhanced mRNA stability [19] [20] [21] [22] [23] . However, the clinical relevance of in vitro-induced CaCDR1 expression of C. albicans is not well understood. The present study provides evidence of an in vitro-induced antagonism between tested drugs [FLC (fluconazole), KTC (ketaonazole), MCZ (miconazole) and CHX (cycloheximide)] and CaCDR1/CaCDR2 inducers [FPZ (fluphenazine), PRG (progesterone) and β-EST (β-oestradiol)], which occur mainly by transiently and reversibly induced expression of CaCDR1 in clinical AS. We further show that this in vitro rapid, transient and reversible induced CaCDR1 overexpression in AS isolates is solely contributed by its transcriptional activation with no change in its mRNA stability or 3 -UTR polyadenylation status.
MATERIALS AND METHODS

Materials
Medium and other chemicals were obtained from Hi-Media (Mumbai, India). Luria-Bertani broth and agar media was purchased from Difco, BD Biosciences. FPZ, PRG, β-EST, KTC, MCZ, CHX and R6G (rhodamine6G) were purchased from Sigma Chemical Co. (St. Louis, MO, U.S. A.) . Oligonucleotides used were commercially synthesized by Sigma-Aldrich (Table 1) . All molecular biology grade chemicals used in the present study were obtained from Sigma Chemical Co.
Bacterial and yeast strains and growth media
Plasmids and C. albicans strains used are listed in Tables 1 and 2 respectively. For induction experiments, C. albicans cells at midexponential phase were pretreated with FPZ (10 μg/ml), PRG (1 mM) and β-EST (1 mM) for 30 min unless otherwise indicated. The final concentrations used are given in parentheses.
Drug susceptibility testing
Susceptibilities to different drugs (see the Figure 1a legend for drug concentrations used) were tested by spotting cells on to solid agar plates either alone or in the presence of FPZ, PRG and β-EST as described previously [24] . Yeast cultures were grown overnight in YEPD (yeast extract peptone dextrose) medium and diluted to a density of 1.5 × 10 7 cells/ml and 10-fold serial dilutions were performed to a final dilution step containing 1.5 × 10 3 cells/ml. Then, 5 μl of each dilution was spotted on to YEPD plates with or without drugs. Plates were photographed after 48 h of incubation at 30
• C.
Checkerboard titre assay
The interaction between the tested drugs namely FLC, KTC, MCZ, CHX and CaCDR1/CaCDR2 inducers namely FPZ, PRG and β-EST was evaluated by the checkerboard method as recommended by the NCCLS. In brief, serial double dilutions of tested anticandidal compounds and inducers were prepared (in μg/ml) ranging from 0.25 to 128 for FLC, 0.019 to 10 for KTC, 0.019 to 10 for MCZ, 0.039 to 20 for CHX and 0.097 to 50 for FPZ, 0.017 to 10 for both PRG and β-EST respectively. After making dilutions, a 100 μl suspension of Candida strains adjusted to 5 × 10 5 CFU (colony forming units)/ml was added to each well and cultured at 30
• C for 48 h in RPMI 1640 medium. 
R6G efflux assay
Glucose-mediated efflux of R6G was carried out as described earlier [28] . Briefly, approx. 1.0 × 10 7 cells from a culture grown overnight were inoculated in 50 ml of YEPD and grown for 3 h at 30
• C. Approx. 30 min before harvesting, cells were pretreated with FPZ (10 μg/ml), PRG (1 mM) and β-EST (1 mM). The cells were pelleted, washed twice with PBS without glucose and subsequently resuspended as 2% cell suspension in PBS without glucose. The cells were then de-energized for 45 min in DOG (deoxy-glucose; 5 mM) and DNP (2,4-dinitrophenyl; 5 mM) in PBS without glucose. The de-energized cells were pelleted, washed and resuspended as 2% (w/v) cell suspension in PBS without glucose to which R6G was added at a final concentration of 10 μM and incubated for 40 min at 30
• C. The equilibrated cells with R6G were then washed and resuspended as 2% (w/v) cell suspension in PBS with 2% (w/v) glucose. An aliquot of 1 ml was taken after the indicated time and centrifuged at 9000 g for 2 min. The absorption of the supernatant was measured at 527 nm.
RNA isolation and Northern-blot hybridization
RNA isolation and Northern-blot analyses were carried out essentially by standard protocols as described earlier [29] . Equal loading of RNA was assessed by rRNA bands. RNA was electrophoresed on denaturing formaldehyde gel and blotted and UV cross-linked on to nylon membranes (Hybond-N + ; Amersham Pharmacia Biotech). Membrane-bound RNA was stained with Methylene Blue before hybridization to check rRNA bands for equal loading and transfer. The relative intensities of CaCDR1 and ACT1 mRNA signals in Northern hybridizations were quantified by exposure of the hybridized membrane in an FLA5000 Fuji PhosphoImager. The list of primers used for making the probes is given in Table 1 .
β-Galactosidase reporter assay
The β-galactosidase reporter assay was performed using duplicate samples of cells from three independent experiments as described previously [8] . 
β -Galactosidase activity (Miller units)
where t is the time of reaction expressed in minutes and v is the culture volume assayed expressed in millilitres.
TRO (transcription run on) assay
TRO experiments were performed as described previously [8] with the following modifications. Cells were grown at 30
• C in YEPD with agitation until the culture reached an D 600 of 1.0 and pretreated with FPZ (10 μg/ml), PRG (1 mM) or β-EST (1 mM) for 30 min. An aliquot of yeast cells (6 × 10 8 ml −1 ) was used to perform TRO. The cells were centrifuged for 5 min at 4000 g and resuspended in 5 ml of cold TMN (10 mM Tris, 100 mM NaCl and 5 mM MgCl 2 , pH 7.4). The cells were again centrifuged for 5 min at 4000 g and the cell pellet was resuspended in 900 μl of sterile cold DEPC (diethyl pyrocarbonate)-treated water. Then the cell suspension was transferred to a fresh microcentrifuge tube containing 50 μl of 10% N-dodecyl sarcosine sodium sulfate (sarkosyl) and was incubated for 20 min on ice. After the permeabilization step, cells were recovered by low-speed centrifugation at 2415 g for 2 min at 4
• C and the supernatant was removed. In vivo transcription was reinitiated by resuspending the permeabilized cell fraction in 120 μl of 2.5 × transcription buffer (50 mM Tris/HCl, pH 7.7, 500 mM KCl and 80 mM MgCl 2 ), 16 μl of AGC mix (10 mM each of ATP, GTP and CTP), 6 μl of dithiothreitol (0.1 M), 1 unit of RNase inhibitor/μl, 10 mM phosphocreatine, 1.2 μg of creatine kinase/μl and 15 μl of [α-32 P]UTP (3000 Ci/mmol and 10 μCi/μl). Cells were maintained on ice at all times. The final volume was adjusted to 300 μl with DEPC-treated water and the mix was incubated for 15 min at 30
• C to allow transcription elongation. The reaction was stopped by adding 1 ml of ice-cold DEPC-treated water to the mix. Cells were recovered by centrifugation to remove non-incorporated radioactive nucleotides. Total RNA was isolated using TRIzol ® reagent (Sigma) as per the manufacturer's specifications except
that 200 μl of ice-cold acid-washed 0.4-0.6 mm diameter glass beads (Sigma Chemical Co.) were also used for efficient and complete lysis of permeabilized cells. Isolated total labelled RNA was again precipitated by adding 2.5 M ammonium acetate and an equal volume of propan-2-ol. The mixture was stored overnight at -20
• C. To pellet the RNA, tubes were centrifuged at 13 148 g for 15 min in the micro-centrifuge. The propan-2-ol was removed and the labelled RNA pellet was washed twice with 70% ethanol, dried and resuspended in 100 μl of DEPC-treated water. This double precipitation of RNA was used to minimize DNA contamination. Total extracted RNA was spectrophotometrically quantified. An aliquot was used for specific radioactivity determination in a Tri-CARB 2900 TR liquid scintillation analyser (Packard Instrument Co.). All of the in vivo labelled RNA of each isolate (∼2-2.5 × 10 6 c.p.m.) was subsequently used for reverse Northern hybridization with a dot-blotted nylon membrane (Hybond-N + ; Amersham Pharmacia Biotech) containing PCR amplified gene-specific N-terminal CaCDR1 sequences (nt -242 to +256 from the TSP), ACT1 (positive control) and pBlueScript-KS(+) (negative control) as probes, as per the manufacturer's recommendations. Northern blots were scanned with a phosphoimager scanner (FLA-5000, Fuji PhosphoImager). Signal intensities of hybridized nuclear RNA were quantified using densitometry scanning.
Thiolutin chase assay
A potent in vivo transcriptional inhibitor, thiolutin was used to measure the CaCDR1 mRNA t1 / 2 (half-life) as described previously [8, 18] . Briefly, 100 ml of cells was grown to a D 600 of 1.0 at 30
• C and pretreated with FPZ (10 μg/ml), PRG (1 mM) or β-EST (1 mM) for 30 min. Transcription was subsequently stopped by the addition of an optimized concentration (40 μg/ml) of thiolutin. Aliquots of cells were taken at the indicated times after transcriptional shut-off by thiolutin. Total RNA was isolated using Ambion's RiboPure TM -Yeast RNA isolation kit (catalogue no. 1926) as per the manufacturer's instructions. Equal RNA loading was assessed by staining the agarose gel with ethidium bromide prior to blotting. For Northern blots, approx. 25 μg of total RNA from the above samples was hybridized with a single probe derived from CaCDR1-specific primers (primer pairs: KM1 and KM2; Table 1 ), which has been used throughout the present study. Hybridization signal intensity was quantified with a phosphoimager scanner (FLA-5000, FLA5000 Fuji PhosphorImager) and normalized to the band intensity at time T 0 and plotted as a line graph.
PAT (polyadenylation test)
An improved variation of 3 -RACE (3 -rapid amplification of cDNA ends) PAT involving G-tailing of mRNA was employed to determine poly(A) tail length as described previously [8, 18] .
Guanylation of mRNA
Total RNA isolated from mid-exponential phase grown untreated or 30 min pretreated [FPZ (10 μg/ml), PRG (1 mM) and β-EST (1 mM)] AS isolates using TRIzol ® reagent (as per the manufacturer's specifications) were enriched with poly(A) + (polyadenylated) mRNA using the Oligotex mRNA Mini kit protocol (Qiagen). The purified poly(A) + -enriched mRNA was used directly for polyguanylation using yeast PAP [poly(A) polymerase] (catalogue no. E74225Y; Amersham Pharmacia Biotech/US Biochemicals) as per the manufacturer's recommendations. To abolish the higher-ordered secondary structure at the 3 -end of mRNA, samples (0.1 μg) were heated at 65
• C for 5 min and immediately placed on ice. They were incubated for 1 h at 37
• C with 600 units of PAP and 0.5 mM GTP in a 25 μl reaction mixture containing 20 mM Tris/HCl (pH 7.0), 50 mM KCl, 0.7 mM MnCl 2 , 0.2 mM EDTA, 100 μg/ml BSA and 10% glycerol. An additional 300 units of PAP were added and incubation was continued for an additional 1 h. The reaction was terminated by heat treatment at 65
• C for 10 min, chilled on ice and kept at -80 • C until further use.
RT-PCR (reverse transcription-PCR)
Polyguanylated mRNA (as described above) was applied directly for RT-PCR analysis using hot start conditions (65
• C, 30 s). The first strand cDNA synthesis (RT, 42
• C for 1 h) was primed by oligo(dC 9 T 6 )-anchor primer (1 μM). The RT reaction was stopped by denaturation at 70
• C for 10 min; the Figure 1 Drug-resistant inducibility of clinical AS isolates (a) Drug susceptibility testing. Drug susceptibility in the presence of inducers (FPZ, PRG and β-EST) was measured by spot assays either alone or along with the indicated drugs as described under the Material and methods section. The final drug concentrations used (the solvent used is given in parentheses) for clinical AS isolates were: FLC 2 μg/ml (water), KTC 0.05 μg/ml (methanol), MCZ 0.1 μg/ml (methanol) and CHX 300 μg/ml (water). For WT parental (CAF2-1), cdr1, cdr2 and cdr1/ cdr2 null strains, the final FLC concentration used was 0.5 μg/ml. Transcript levels of CaCDR1 and CaCDR2 in uninduced and induced AS isolates were detected by Northernblot analysis. The membranes were subsequently de-probed and rehybridized with the ACT1 probe to monitor equal RNA loading and transfer. Hybridization signal intensities of CaCDR1 and CaCDR2 transcript levels were quantified using densitometry scanning of phosphoimages. Relative intensity (RI) of CaCDR1 and CaCDR2 transcript levels with respect to corresponding ACT1 mRNA of each AS isolate is plotted. Un, uninduced.
synthesized cDNA product (1:4 dilution) was used for PCR amplification with 1 μM of each CaCDR1 3 -UTR specific forward primers, Gu4/DSY294-UTR-F-RM and reverse anchor primer (AP-RM) as mentioned in Table 1 (PCR parameters: initial denaturation of 95 • C for 5 min followed by 35 cycles denaturation at 95
• C for 30 s, annealing at 55
• C for 30 s, elongation at 72
• C for 1 min and final extension at 72
• C for 10 min). As a positive control, CaCDR1 ORF (open reading frame)-specific forward and reverse primers, CT-CDR1-F-RM and CT-CDR1-R-RM (corresponding to position 4271-4293 and 4475-4503 in the CaCDR1 genomic sequence) were also used (results not shown). The negative control (without RT) established that the PCR products generated in the RT-PCR were not due to genomic DNA contamination (results not shown). The RT-PCR product of each isolate was electrophoresed on a 1.2% agarose gel in 1 × TAE (Tris/acetate/EDTA). The gel-purified 3 -RACE product (Qiagen PCR clean up kit) of each isolate was cloned directly in pGEM ® T-Easy vector using T/A cloning kit (Promega) as per the manufacturer's recommendations. All the cloned RT-PCR amplified products were confirmed by appropriate restriction digestion analysis and sequenced further to determine the exact and precise length of CaCDR1 transcript poly(A) tail.
Custom service nucleotide sequencing
Multiple CaCDR1 3 -UTR specific clones harbouring poly(A) tail length of each isolate (as described above) were sequenced directly by extension from both sense and anti-sense strands using T7 promoter/T7 promoter primer and SP6 promoter/SP6 promoter primer (Table 1) by exploiting Big Dye terminator chemistry and automated DNA sequencing (ABI Prism 3100). Approx. 8-10 random clones from at least three independent RT-PCR reactions of each isolate were sequenced. Reproducibility of the sequencing was confirmed by processing all samples at least twice.
RESULTS
In vitro-induced drug resistance in clinical AS isolates display up-regulation of CaCDR1 and CaCDR2
To check the inducible drug-resistance potential, AS isolates (Gu4 and DSY294) were spotted on YEPD plates containing drugs such as FLC, KTC, MCZ and CHX in the presence of wellknown CaCDR1 inducers such as FPZ, PRG and β-EST [10] . Gu4 and DSY294 strains in the presence of the tested inducers showed marked increase in MDR (Figure 1a) . Notably, the presence of inducers in cdr1 (DSY449) as well as in cdr1/ cdr2 (DSY654) null cells did not cause any significant change in susceptibilities to tested drugs (Figure 1a) . However, exposure of inducers to cdr2 null cells (DSY653) and its corresponding parental WT (wild-type) cells exhibited relatively enhanced res- istance to tested drugs (Figure 1a) . The results of the spot assays were further confirmed by checkerboard assays. Table 3 summarizes the FICI values of AS isolates (Gu4 and DSY294), cdr2 null cells (DSY653) and its corresponding WT strain (CAF2-1) in the presence of the inducers (FPZ, PRG and β-EST) and tested drugs (FLC, KTC, MCZ and CHX). The FICI values were higher than 4 in each case, thus confirming antagonism observed in spot assays. Notably, an FICI value above 4 confirms antagonism between the tested drugs and the inducers [25] . In the case of cdr1 (DSY449), cdr1/ cdr2 (DSY654) nulls and AR isolates (Gu5 and DSY296), there was no significant difference in the MIC 80 (minimal inhibitory concentration for 80% of input cells) values of FLC, KTC, MCZ and CHX in the presence of inducers (results not shown). The enhanced efflux of R6G, a well-known substrate of CaCdr1p in induced AS isolates (1.8-, 2.3-and 1.8-fold for Gu4 and 2.0-, 2.3-and 2.2-fold for DSY294, in the presence of FPZ, PRG and β-EST respectively; Figure 1b) , further supports the observed antagonism. Northern-blot analysis in induced and non-induced cells scraped from the plates mimicking the conditions of spot assays, displayed relatively higher CaCDR1 and CaCDR2 transcripts levels (Figure 1c) . Considering the fact that CaCDR1 up-regulation elicits enhanced resistance to tested drugs as compared with CaCDR2 (Figure 1a) , we focused on detailed analysis of CaCDR1. The possible involvement of other genes, however, in induction of MDR phenotype in AS isolates cannot be ruled out. Notably, no difference in drug-resistance profiling, R6G efflux and CaCDR1 transcript levels for both uninduced and induced AR isolates was observed (Supplementary Figure S1 at http://www.biosci.org/bsr/031/bsr0310031add.htm).
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Induced up-regulation of CaCDR1 is mediated by its transcriptional activation
We evaluated if observed induced CaCDR1 up-regulation was due to its transcriptional activation. For this, we used two different approaches. First, we performed the β-galactosidase reporter assay in which CaCDR1 promoter was placed upstream of the lacZ reporter [8] . Interestingly, β-galactosidase activity observed in both the induced AS isolates was relatively higher than their corresponding untreated counterparts (Figure 2a ; 4.5-, 4.6-and 5.4-fold for Gu4 and 3.3-, 7.6-and 6.6-fold for DSY294 in the presence of FPZ, PRG and β-EST respectively). To validate this further, we examined the CaCDR1 promoter activity in its native chromosomal context by TRO experiments. TRO analyses of newly transcribed RNA were done on permeabilized cell fraction harbouring the intact nuclei isolated from uninduced and induced AS strains, as described previously [8] . As depicted in Figure 2 
Rapid inducible CaCDR1 transcription activation is transient and reversible
The clinical AS isolates were subjected to Northern-blot analysis up to 2 h of challenge with the inducers. As depicted in Figure 3(a) , CaCDR1 mRNA levels in both the induced AS isolates declined with time. The noted gradual reduction in CaCDR1 promoter-driven β-galactosidase reporter activity substantiated the Northern-blot results (Figure 3b) . Coinciding with these results, there was also a decline in the magnitude of CaCDR1 run-on transcriptional rate with time which paralleled the levels of the endogenous mRNA (Figure 3c) . Taken together, an overall kinetics analysis by Northern, reporter and TRO assays (Figures 3a-3c ) confirmed that in vitro-induced CaCDR1 expression in AS isolates is transient and reverts to basal level within 2 h of treatment (Figures 2 and 3 ).
CaCDR1 transcript stability does not change in induced AS isolates
Because the increase in steady-state CaCDR1 mRNA was due to de novo mRNA synthesis, we explored if changes in its mRNA decay rates, could also contribute to its transiently induced levels. For determining the CaCDR1 mRNA t1 / 2 in uninduced and induced AS strains, we treated cells with thiolutin to inhibit in vivo transcription [8] . Total RNA was isolated at different time points after blocking the transcription and was analysed by RNA gel blots (Figure 4a) . After probing the blots with a CaCDR1-specific probe, CaCDR1 mRNA could be detected in both the induced AS isolates at time T 0 and the signal intensity diminished progressively with time at a rate (mRNA t1 / 2 was ∼60 min) similar to that of uninduced AS isolates (Figure 4b) . Neither of the induced AS isolates showed any significant change in poly(A) tail length of CaCDR1 3 -UTR (Table 4 ; a maximum variation of + − 2 bases was observed between different clones). A minimum of ten random clones were subjected to sequencing to determine the precise poly(A) tail length.
DISCUSSION
Our present work addresses and differentiates the induced drugresistance mechanism(s) from acquired resistance of C. albicans. We show by spot and checkerboard titre assays that antagonism between inducers (FPZ, PRG and β-EST) of efflux pump encoding genes, CaCDR1/CaCDR2 and tested drugs (FLC, KTC, MCZ and CHX) reduces the susceptibility of AS isolates mainly via up-regulation of CaCDR1 (Figures 1a-1c and Table 3 ). The spot assays of cdr1 showed that despite induced CaCDR2 transcript levels, there was no significant increase in drug resistance (Figure 1a ), indicating that, in contrast to CaCDR1, the
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C The Authors Journal compilation C 2011 Biochemical Society contribution of CaCDR2 in the development of in vitro-induced drug resistance is limited. These results are in agreement with earlier reports where in contrast to CaCDR2 expression, a relatively higher transient inducible response of CaCDR1 transcript is observed in FLC-susceptible isolates [10] .
Regulation of azole resistance in Candida albicans
Although in a previous study by Coste et al. [14] , it has been reported that CaCDR1/CaCDR2 can be up-regulated in AS isolates by exposing the cells transiently to drug (FPZ) and steroid (β-EST). Accordingly, a 22-bp DRE containing two 6-bp repetitive elements with 5 -CGG-3 triplets and corresponding TF, TAC1 has been shown to be required for the transient induction of CaCDR1/CaCDR2 [14] . However, the functionality and molecular mechanisms of the transiently induced CaCDR1 in regulating the induced MDR phenotype of AS isolates remains to be examined. Thus, considering that CaCDR1 plays a major role in induced MDR in C. albicans, this study is focused to as compared with untreated cells (considered as '1') from three independent experiments. (c) TRO analysis. TRO assays were done on permeabilized cell fractions harbouring the intact nuclei from AS isolates at the indicated times after addition of inducers. The labelled nuclear run-on RNA for each indicated time point was hybridized to ACT1 and CaCDR1 specific PCR amplicon, which were immobilized by dot-blotting on to a nylon membrane. Relative positions of the individual dot-blots on the nylon membrane are shown in the scheme (middle-top). Un, uninduced. dissect the molecular mechanism underlying the transiently induced up-regulation of its transcript levels. Our present analysis of CaCDR1 up-regulation in clinical AS isolates revealed that the tested inducers activate a transient and reversible up-regulation of CaCDR1 which is solely contributed by its transcriptional activation. The reporter gene transcription and TRO assays confirmed the enhanced transcriptional rate of CaCDR1 in induced AS isolates (Figures 2a and 2b) . This also matched well with the occurrence of drug and steroid responsive DRE sequence in its proximal promoter [10] . Subsequent, kinetic analysis revealed that induced transcriptional up-regulation of CaCDR1 was reversible as its expression reverted back to basal level within 2 h exposure of cells to the inducers (Figures 3a-3c) . The overexpressed CaCDR1 as well as CaCDR2 probably lead to enhanced efflux of tested inducers resulting in its reduced intracellular concentration. We hypothesized that there might exist a negative feedback mechanism where the inducer itself shuts down its effect; however, we do not have data to support this notion. This is indeed in contrast to MDR phenotype of corresponding AR isolates, where sustained higher CaCDR1 transcript levels are maintained not only by its transcriptional activation but also by post-transcriptional events involving enhanced stability and hyperadenylation of its transcript [18] .
Although transcriptional regulation seems to be the major control point, post-transcriptional mechanism such as the mRNA stability has also been shown to regulate the transientinduced MDR phenotype in many human cell lines. For example, T-lymphoblastoid MDR cell line (CCRF VCR 100) show relatively increased mRNA stability of hMDR1 after actinomycin D exposure, with no change in its transcription rate [30] . In leukaemic cell lines, an increased mRNA level of hMDR1 on transient exposure to a variety of cytotoxic drugs, during liver regeneration, and on depletion of mitochondrial DNA in HCT-8 colon cancer cell lines was reported to be solely due to its enhanced mRNA stability [22, 31, 32] . In another study, CHX induction increased the length of 3 -UTR of class II P-gp transcript levels; however, whether this led to an enhanced mRNA stability was not examined in that study [33] . Notably, an increase in EhPgp5 mRNA levels of resistant phenotype of Entamoeba histolytica trophozoites at high emetine concentration was contributed by its transcriptional activation as well as by enhanced mRNA t1 / 2 , along with the lengthening of poly(A) tail [34] . However, our post-transcriptional analysis of induced AS strains revealed no change in CaCDR1 mRNA stability (Figures 4a and 4b ) or in its 3 -UTR polyadenylation status (Table 4) . Thus, the effects of inducers in up-regulating CaCDR1 transcript levels are restricted solely to its transcriptional activation.
From the matched pair of AS and AR strains, it appears likely that a stepwise accumulation of mutation(s)/recombination(s) could occur within AS isolates during azole chemotherapy, resulting in an enhanced transcript levels of CaCDR1. That a hyperactive gain-of-function mutation (N977D) in TAC1 causes CaCDR1 up-regulation in one of our studied AR isolates (DSY296) would support this notion [35] . Notably, CaMDR1 and CaERG11 overexpression in other AR isolates have also been reported to be due to hyperactive mutations in their corresponding TFs MRR1 (P683S, G997V) and UPC2 (G648D, A643T) respectively [36] [37] [38] . Earlier Karababa et al. [39] had compared gene expression profiles of FPZ-induced AS isolates and CaCDR1 overexpressing AR isolates and showed that in vitro-induced gene expression only partly mimics the expression profile of AR isolates [39] . Thus, there are differences in regulatory mechanisms between induced versus acquired drug resistance of clinical AS and AR isolates respectively. In this context, our results show differences in regulations that exist between induced AS and uninduced AR isolates at the level of a single major MDR gene, CaCDR1. Our results, therefore, not only make a first-time distinction between induced and acquired activation of CaCDR1 transcript levels but also opens possibilities for the development of therapeutic strategies to target either in vitro or in vivo developed drugresistance in C. albicans. In this context, it should be noted that the intervention of overexpressing P-gp in MDR cell lines by natural and synthetic inhibitors has already been reported to be due to its specific transcriptional down-regulation [40] [41] [42] [43] . 
Figure S1 Non-inducibility of AR isolates
(a) Drug susceptibility testing. Drug susceptibilities of AR isolates in the presence of inducers (FPZ, PRG and β-EST) were measured by spot assays either alone or for the indicated drugs as described in the Materials and Methods section in the main paper. The final drug concentrations used (the solvent used is given in parentheses) were: FLC, 5 μg/ml (water); KTC, 0.05 μg · ml (methanol); MCZ, 0.1 μg/ml (methanol); and CHX, 300 μg/ml (water). Susceptibilities to various drugs were checked in YEPD. In the spot assay, 5 μl of 10-fold serial serial dilutions of each yeast culture (1.5×10 7 cells/ml) was spotted on to YEPD plates in the absence (control) and the presence of the indicated inducers/drugs. (b) R6G efflux assay. The assay was performed essentially as described in the Materials and Methods section in the main paper. The results are shown as relative fold induction of R6G efflux from induced AR isolates as compared with corresponding uninduced cells (considered as '1'). The results reported are means+ − S.D. of three independent experiments. (c) Northern blot analysis. Transcript levels of CaCDR1 in uninduced and induced AR isolates were detected by Northern blot analysis. The membranes were subsequently de-probed and re-hybridized with the ACT1 probe to monitor equal RNA loading and transfer. Un, uninduced.
